Literature DB >> 6580771

Human osteogenic sarcoma: fine structure of the osteoblastic type.

A Stark, T Aparisi, J L Ericsson.   

Abstract

The fine structure of representative regions of 13 osteoblastic osteogenic sarcomas was studied. These regions contained four morphologically distinguishable subtypes of osteoblastlike cells. In addition, fibroblastlike and chondroblastlike cells were present, along with multinucleated giant cells, leukocytes, macrophagelike cells, and small populations of histogenetically unclassifiable (but probably neoplastic) cells. The morphologic evidence was compatible with the view that the variations in appearance among the subgroups of osteoblastlike cells reflected differences in maturation and differentiation of these cells. In at least one subgroup, the morphologic findings suggested that the cells were capable of manufacturing a secretory product. The multinucleated giant cells occurring in genuine tumor areas appeared to be closely related to neoplastic osteoblasts. The presence of chondroblastlike cells in the tissues illustrates that cells with a diverging differentiation can occur in an osteoblast-dominated cell population. This agrees with the view that the neoplastic cells originate from a mesenchymal stem cell with potential for multifaceted differentiation.

Entities:  

Mesh:

Year:  1983        PMID: 6580771     DOI: 10.3109/01913128309140584

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  2 in total

1.  Risk factors in the development of stem cell therapy.

Authors:  Carla A Herberts; Marcel S G Kwa; Harm P H Hermsen
Journal:  J Transl Med       Date:  2011-03-22       Impact factor: 5.531

2.  The microenvironment-specific transformation of adult stem cells models malignant triton tumors.

Authors:  Mitra Lavasani; Jonathan B Pollett; Arvydas Usas; Seth D Thompson; Aaron F Pollett; Johnny Huard
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.